Singleversustandem high-dose melphalan followed by autologous blood stem cell transplantation in multiple myeloma: long-term results from the phase III GMMG-HD2 trial-Reference-Cited by-同舟云学术

Singleversustandem high-dose melphalan followed by autologous blood stem cell transplantation in multiple myeloma: long-term results from the phase III GMMG-HD2 trial

Published:2016-03-17 Issue:5 Volume:173 Page:731-741
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Mai Elias K.¹^ORCID,Benner Axel²,Bertsch Uta¹³,Brossart Peter⁴,Hänel Annette⁵,Kunzmann Volker⁶,Naumann Ralph⁷,Neben Kai⁸,Egerer Gerlinde¹,Ho Anthony D.¹,Hillengass Jens¹,Raab Marc S.¹^ORCID,Neubauer Andreas⁹,Peyn Astrid¹⁰,Ko Yon-Dschun¹¹,Peter Norma¹²,Scheid Christof¹³,Goldschmidt Hartmut¹³

Affiliation:

1. Department of Internal Medicine V; University Clinic Heidelberg; Heidelberg Germany

2. Division of Biostatistics; German Cancer Research Centre (DKFZ); Heidelberg Germany

3. Nationales Centrum für Tumorerkrankungen (NCT) Heidelberg; Heidelberg Germany

4. Medical Clinic and Polyclinic III; University Hospital Bonn; Bonn Germany

5. Department of Internal Medicine III; Klinikum Chemnitz; Chemnitz Germany

6. Department of Internal Medicine II; University Clinic Würzburg; Würzburg Germany

7. Department of Medicine I; University Hospital Dresden Carl Gustav Carus; Dresden Germany

8. Department of Haematology and Oncology; Klinikum Baden Baden; Baden Baden Germany

9. Department of Haematology and Oncology; University Clinic Gießen/Marburg; Marburg Germany

10. Department of Internal Medicine I; Klinikum Bremen Mitte; Bremen Germany

11. Department of Haematology and Oncology; Evangelische Kliniken Bonn; Bonn Germany

12. Department of Internal Medicine II; Carl-Thiem Klinikum Cottbus; Cottbus Germany

13. Department of Internal Medicine I; University Hospital Köln; Köln Germany

Funder

Amgen

Novartis

Roche

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.13994/fullpdf

Reference36 articles.

1. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma;Attal;New England Journal of Medicine,1996

2. Single versus double autologous stem-cell transplantation for multiple myeloma;Attal;New England Journal of Medicine,2003

3. Lenalidomide maintenance after stem-cell transplantation for multiple myeloma;Attal;The New England Journal of Medicine,2012

4. Superiority of tandem autologous transplantation over standard therapy for previously untreated multiple myeloma;Barlogie;Blood,1997

5. Total therapy with tandem transplants for newly diagnosed multiple myeloma;Barlogie;Blood,1999

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. No Role for Tandem Autologous Stem Cell Transplantation in Modern Treatment Paradigms for Transplant Eligible Multiple Myeloma;Transplantation and Cellular Therapy;2024-09

2. Множественная миелома: моделирование сценариев терапии с использованием метода Монте-Карло;Clinical Oncohematology;2024-07-01

3. The Efficacy and Safety of Tandem Transplant Versus Single Stem Cell Transplant for Multiple Myeloma Patients: A Systematic Review and Meta-Analysis;Diagnostics;2024-05-16

4. Historical Perspective of High-Dose Therapy Followed by Autologous Stem Cell Transplantation in Multiple Myeloma;Acta Haematologica;2024-05-06

5. Comparative analysis of single versus tandem autologous stem cell transplantation in patients with multiple myeloma in Korea: the KMM2102 study;2024-04-30